Truveta logoCompany profile

Truveta

Truveta has raised a total of $515 million in funding over multiple rounds, achieving unicorn status in January 2025. Its latest Series C round of $320 million, closed on January 13, 2025, was backed by Providence Health & Services and Trinity Health. Founded in 2020 and headquartered in Seattle, United States, Truveta provides a life sciences and healthcare IT platform that aggregates anonymized patient data to enable AI-driven medical research and improved clinical outcomes. The company continues to expand globally in life sciences tech and healthcare IT.

Back to profiles

Quick facts

Total funding
$515 million
Founded
2020
Headquarters
Seattle, United States, Truveta provides a life sciences and healthcare IT platform that aggregates anonymized patient data to enable AI-driven medical research and improved clinical outcomes

Notable investors

  • Providence Health & Services
  • Trinity Health

Reach buyers like Truveta.

The 14-day trial ships every feature, no card required.